Song Mingyang, Willett Walter C, Hu Frank B, Spiegelman Donna, Must Aviva, Wu Kana, Chan Andrew T, Giovannucci Edward L
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
Int J Cancer. 2016 May 15;138(10):2383-95. doi: 10.1002/ijc.29981. Epub 2016 Feb 8.
The influence of adiposity over life course on cancer risk remains poorly understood. We assessed trajectories of body shape from age 5 up to 60 using a group-based modeling approach among 73,581 women from the Nurses' Health Study and 32,632 men from the Health Professionals Follow-up Study. After a median of approximately 10 years of follow-up, we compared incidence of total and obesity-related cancers (cancers of the esophagus [adenocarcinoma only], colorectum, pancreas, breast [after menopause], endometrium, ovaries, prostate [advanced only], kidney, liver and gallbladder) between these trajectories. We identified five distinct trajectories of body shape: lean-stable, lean-moderate increase, lean-marked increase, medium-stable, and heavy-stable/increase. Compared with women in the lean-stable trajectory, those in the lean-marked increase and heavy-stable/increase trajectories had a higher cancer risk in the colorectum, esophagus, pancreas, kidney, and endometrium (relative risk [RR] ranged from 1.22 to 2.56). Early life adiposity was inversely while late life adiposity was positively associated with postmenopausal breast cancer risk. In men, increased body fatness at any life period was associated with a higher risk of esophageal adenocarcinoma and colorectal cancer (RR ranged from 1.23 to 3.01), and the heavy-stable/increase trajectory was associated with a higher risk of pancreatic cancer, but lower risk of advanced prostate cancer. The trajectory-cancer associations were generally stronger for non-smokers and women who did not use menopausal hormone therapy. In conclusion, trajectories of body shape throughout life were related to cancer risk with varied patterns by sex and organ, indicating a role for lifetime adiposity in carcinogenesis.
肥胖在生命历程中对癌症风险的影响仍知之甚少。我们采用基于群组的建模方法,在护士健康研究中的73581名女性和健康专业人员随访研究中的32632名男性中,评估了从5岁到60岁的体型轨迹。经过约10年的中位随访后,我们比较了这些轨迹之间的总体癌症以及与肥胖相关癌症(仅食管腺癌、结直肠癌、胰腺癌、绝经后乳腺癌、子宫内膜癌、卵巢癌、仅晚期前列腺癌、肾癌、肝癌和胆囊癌)的发病率。我们确定了五种不同的体型轨迹:瘦且稳定型、瘦且适度增加型、瘦且显著增加型、中等稳定型以及胖且稳定/增加型。与瘦且稳定轨迹的女性相比,瘦且显著增加型和胖且稳定/增加型轨迹的女性在结直肠癌、食管癌、胰腺癌、肾癌和子宫内膜癌方面患癌风险更高(相对风险[RR]范围为1.22至2.56)。早年肥胖与绝经后乳腺癌风险呈负相关,而晚年肥胖与绝经后乳腺癌风险呈正相关。在男性中,任何生命阶段体脂增加都与食管腺癌和结直肠癌风险更高相关(RR范围为1.23至3.01),胖且稳定/增加型轨迹与胰腺癌风险更高相关,但与晚期前列腺癌风险较低相关。轨迹与癌症的关联在不吸烟者和未使用绝经激素治疗的女性中通常更强。总之,一生的体型轨迹与癌症风险相关,且因性别和器官呈现不同模式,表明终生肥胖在致癌过程中发挥作用。